» Articles » PMID: 23593463

A Non-synonymous Coding Variant (L616F) in the TLR5 Gene is Potentially Associated with Crohn's Disease and Influences Responses to Bacterial Flagellin

Overview
Journal PLoS One
Date 2013 Apr 18
PMID 23593463
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Although numerous studies have implicated TLR5, or its ligands, bacterial flagellins, in the pathogenesis of Crohn's disease (CD), genome-wide association studies (GWAS) have not reported associations with the TLR5 gene. We aimed to examine potential CD-associated TLR5 variants and assess whether they modified inflammatory responses to bacterial flagellins.

Methods And Principal Results: A two-stage study was carried out. In stage 1, we genotyped tagging single-nucleotide polymorphisms (tag-SNPs) in the TLR5 gene in a sample of CD cases (<20 years of age, N = 566) and controls (N = 536). Single SNP and haplotype analysis was carried out. In Stage 2, we assessed the functional significance of potential CD-associated variant(s) vis-à-vis effects on the inflammatory response to bacterial flagellin using HEK293T cells. We observed marginal association between a non-synonymous coding SNP rs5744174 (p = 0.05) and CD. Associations between SNP rs851139 that is in high linkage disequilibrium (LD) with SNP rs5744174 were also suggested (p = 0.07). Haplotype analysis revealed that a 3 marker haplotype was significantly associated with CD (p = 0.01). Functional studies showed that the risk allele (616F) (corresponding to the C allele of SNP rs5744174) conferred significantly greater production of CCL20 in response to a range of flagellin doses than the comparator allele (616L).

Conclusions: Our findings suggest that a non-synonymous coding variation in the TLR5 gene may confer modest susceptibility for CD.

Citing Articles

Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis.

Membrive-Jimenez C, Perez-Ramirez C, Arias-Santiago S, Richetta A, Ottini L, Pineda-Lancheros L Int J Mol Sci. 2023; 24(10).

PMID: 37240048 PMC: 10218224. DOI: 10.3390/ijms24108703.


Play the plug: How bacteria modify recognition by host receptors?.

Tiruvayipati S, Hameed D, Ahmed N Front Microbiol. 2022; 13:960326.

PMID: 36312954 PMC: 9615552. DOI: 10.3389/fmicb.2022.960326.


Comparative host transcriptome in response to pathogenic fungi identifies common and species-specific transcriptional antifungal host response pathways.

Bruno M, Dewi I, Matzaraki V, Ter Horst R, Pekmezovic M, Rosler B Comput Struct Biotechnol J. 2021; 19:647-663.

PMID: 33510868 PMC: 7817431. DOI: 10.1016/j.csbj.2020.12.036.


Toward a porcine model to analyze the pathogenesis of TLR5-dependent enteropathies.

Pieper R, van Best N, Vorst K, Ebner F, Reissmann M, Hornef M Gut Microbes. 2020; 12(1):1782163.

PMID: 32715918 PMC: 7524303. DOI: 10.1080/19490976.2020.1782163.


rs5744174 gene polymorphism is associated with the virus etiology of infant bronchiolitis but not with post-bronchiolitis asthma.

Tormanen S, Terasjarvi J, Lauhkonen E, Helminen M, Koponen P, Korppi M Health Sci Rep. 2019; 1(6):e38.

PMID: 30623075 PMC: 6266536. DOI: 10.1002/hsr2.38.


References
1.
Targan S, Landers C, Yang H, Lodes M, Cong Y, Papadakis K . Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005; 128(7):2020-8. DOI: 10.1053/j.gastro.2005.03.046. View

2.
Amre D, Mack D, Morgan K, Israel D, Deslandres C, Seidman E . Susceptibility loci reported in genome-wide association studies are associated with Crohn's disease in Canadian children. Aliment Pharmacol Ther. 2010; 31(11):1186-91. DOI: 10.1111/j.1365-2036.2010.04294.x. View

3.
Vijay-Kumar M, Aitken J, Sanders C, Frias A, Sloane V, Xu J . Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J Immunol. 2008; 180(12):8280-5. DOI: 10.4049/jimmunol.180.12.8280. View

4.
Amre D, Mack D, Israel D, Morgan K, Lambrette P, Law L . Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children. Am J Gastroenterol. 2007; 103(3):615-20. DOI: 10.1111/j.1572-0241.2007.01661.x. View

5.
Glocker E, Kotlarz D, Boztug K, Gertz E, Schaffer A, Noyan F . Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009; 361(21):2033-45. PMC: 2787406. DOI: 10.1056/NEJMoa0907206. View